Bimzelx 160 MG/ML autoinjectorml
Ended Awarded
- Contract number
- SPE2DB26FMALC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $35,362
Award facts
- Contract value 100% obligated
- $35,361.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $35,361.68 to AmerisourceBergen Drug Corp for BIMZELX 160 mg/ml auto-injectors, with an ultimate completion date of October 21, 2025. This non-competitive delivery order represents a firm fixed-price pharmaceutical supply transaction executed under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The contractor, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location, consistent with its established role as a primary pharmaceutical distributor for federal medical procurement.
This delivery order is issued under AmerisourceBergen's comprehensive $999,999,999.00 indefinite delivery contract (SPE2DX) with DLA Troop Support Medical, which extends through December 2026 and serves as a global pharmaceutical support vehicle for military healthcare programs. The contract vehicle enables the company to supply a diverse portfolio of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, and medical devices across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen's selection demonstrates its competitive capability to meet federal pharmaceutical procurement requirements, positioning it among multiple potential contractors for DLA's planned Pharmaceutical Prime Vendor Global Program Generation V regional contracts.
Quick answers
Who was awarded contract SPE2DB26FMALC?
SPE2DB26FMALC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 20, 2025.
How much is contract SPE2DB26FMALC worth?
The government has obligated $35,362 on SPE2DB26FMALC.
Is contract SPE2DB26FMALC an order under another contract?
Yes. SPE2DB26FMALC is a delivery order under SPE2DB20D2104, an indefinite delivery contract.
Was contract SPE2DB26FMALC competed?
The extent of competition for SPE2DB26FMALC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award